altRX vs Center for Medical Weight Loss (CMWL)
altRX and Center for Medical Weight Loss (CMWL) both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Center for Medical Weight Loss (CMWL)
Best for: compounded semaglutide at $149/month
Visit Center for Medical Weight Loss (CMWL) →If you are choosing between altRX and Center for Medical Weight Loss (CMWL), price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. altRX leads our six-part score, 7.6 to 7.5. One of the two has an FDA warning letter on record, covered below.
altRX vs Center for Medical Weight Loss (CMWL) price
altRX and Center for Medical Weight Loss (CMWL) start at the same figure, $149 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.
Drug by drug: Semaglutide costs the same at both, $149 a month; tirzepatide is cheaper at Center for Medical Weight Loss (CMWL) ($239 a month vs $249 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format, altRX prices compounded injections and brand-name pens, while Center for Medical Weight Loss (CMWL) prices compounded injections.
If you want the FDA-approved brand rather than a compounded version, altRX is the only one of the two with a brand-name price.
Where each one treats patients
altRX lists 50 states, and Center for Medical Weight Loss (CMWL) does not publish where it ships.
Pricing
altRX
Center for Medical Weight Loss (CMWL)
Standing month\u002dto\u002dmonth rate. /compounded\u002dsemaglutide publishes '3 month plan $116/month | Monthly plan $149/month'; the 3\u002dmonth plan bills for 3 months at $116/mo (349 dollars total). Billing on 3\u002dmonth plans runs every 10 weeks for a 12\u002dweek supply, per the site's own note.
Standing month\u002dto\u002dmonth rate. /compounded\u002dtirzepatide publishes '3 month plan $159/month | Monthly plan $239/month'; the 3\u002dmonth plan bills for 3 months at $159/mo (477 dollars total). Same 10\u002dweek billing cycle on 3\u002dmonth plans.
What each price covers
Both prices cover the clinician visit, the medication itself and shipping.
altRX is silent on lab work and coaching.
Center for Medical Weight Loss (CMWL) is silent on lab work and coaching.
altRX
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Center for Medical Weight Loss (CMWL)
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Where each one scores higher
Overall, altRX scores 7.6 and Center for Medical Weight Loss (CMWL) 7.5 out of 10.
altRX is stronger on accessibility (10.0 vs 5.0).
Center for Medical Weight Loss (CMWL) is stronger on value (6.6 vs 5.0) and trust & safety (6.5 vs 6.0).
Effectiveness, user experience and support are within half a point.
altRX
7.6/10
Center for Medical Weight Loss (CMWL)
7.5/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent altRX a warning letter dated June 8, 2026 (letter 728236), and it is still open.
Center for Medical Weight Loss (CMWL) has no FDA warning letter on record with us.
Features & Coverage
| Feature | altRX | Center for Medical Weight Loss (CMWL) |
|---|---|---|
| Starting Price | $149/mo | $149/mo |
| Features | ✓8 features | 6 features |
| States Available | 50 | Not disclosed |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | 1 letter | ✓None |
About altRX
Compounded plans open at $149 for semaglutide and $249 for tirzepatide. Branded medication runs $1,149-$1,579, a figure that already contains the consult and the shipping. Every one of the four FDA-approved brands is stocked, Mounjaro, Ozempic, Wegovy and Zepbound, which no other entry in our directory matches. altRX works in both modalities, holds LegitScript certification, and prints the FDA compounded-medication disclaimer.
Read our full altRX review →About Center for Medical Weight Loss (CMWL)
Take the three-month plan and the rates fall to 116 and 159 dollars per month; month to month they are 149 dollars for compounded semaglutide and 239 dollars for compounded tirzepatide. Microdosing costs less still. Dose does not change any figure. Everything runs 100 percent online under physician supervision, approval typically lands inside 24 hours, and shipping costs nothing. Certain states cannot take part. Compounded meds are not FDA-approved.
Read our full Center for Medical Weight Loss (CMWL) review →Pros & Cons
altRX
What we like
- Tirzepatide costs $1249 a month, close to the $1249 median for brand-name tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
- Serves all 50 states
- Names 4 pharmacies that fill its prescriptions, which most sellers do not
Watch-outs
- Semaglutide costs $1149 a month, 15% above the $997 median for brand-name semaglutide across the sellers we compare
- The FDA has issued altRX a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Center for Medical Weight Loss (CMWL)
What we like
- Semaglutide costs $149 a month, 19% below the $185 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $239 a month, close to the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits and shipping
- We found no FDA warning letters issued to Center for Medical Weight Loss (CMWL)
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
altRX wins this one, 7.6 to 7.5, above all for semaglutide from $1149/month. Center for Medical Weight Loss (CMWL) fits better if compounded semaglutide at $149/month is your priority.
Choose altRX if…
You want semaglutide from $1149/month and an opening price near $149 a month.
Choose Center for Medical Weight Loss (CMWL) if…
You want compounded semaglutide at $149/month and an opening price near $149 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
HumeCare+
An oral route if you will not self-inject
From $199/mo
Get started →Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →Enhance MD
Knowing which pharmacy fills the vial: it names Tru Meds Rx
From $169/mo
Get started →altRX vs Center for Medical Weight Loss (CMWL): FAQ
Close alternatives to altRX and Center for Medical Weight Loss (CMWL)
- altRX vs Gala
- altRX vs Sprout Health
- altRX vs Aquivia Health
- altRX vs Vytora Health
- Center for Medical Weight Loss (CMWL) vs Trinity Meds
- Center for Medical Weight Loss (CMWL) vs PlushCare
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.